| Zevtera (ceftobiprole) / Basilea |
2022-001837-35: Late-onset sepsis in term and pre-term neonates and infants up to 3 months of age |
|
|
| Ongoing | 3 | 15 | Europe, US | Ceftobiprole medocaril, Powder for concentrate for solution for infusion, Zevtera® | Basilea Pharmaceutica International Ltd, Allschwil, Basilea Pharmaceutica International Ltd, Allschwil | Late-onset sepsis in term and pre-term neonates andinfants up to 3 months of age., Body's extreme reaction to bacterial infection in newborns., Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2019-002027-15: Etude de la pharmacocinétique plasmatique et pulmonaire du ceftobiprole administré à haute dose en perfusion continue dans la pneumonie aiguë communautaire grave sous ventilation mécanique. |
|
|
| Not yet recruiting | 3 | 12 | Europe | Powder for concentrate for solution for infusion, MABELIO 500mg | CHU DE NIMES, CHU DE NIMES | Community acquired pneumonia Pneumonies aiguës communautaires, Community acquired pneumonia Pneumonies aiguës communautaires, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
| Completed | 3 | 9 | Europe, US | Ceftobiprole medocaril | Basilea Pharmaceutica, Basilea Pharmaceutica International Ltd, Allschwil | Neonatal Sepsis | 12/24 | 12/24 | | |
2016-003917-83: Etude de la pénétration méningée de la ceftobiprole chez les patients porteurs d'un dispositif intracranien |
|
|
| Ongoing | 2 | 10 | Europe | Mabelio, Solution for infusion, Mabelio | CHU de DIJON | Infection ou inflammation méningée, méningites, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2017-001327-45: A pilot study of Ceftobiprole diffusion in bone and joint, in patients with BIJ( bone and joint infection) undergoing hip or knee replacement. Etude pilote de dosage du Ceftobiprole dans les infections ostéo-articulaires chez des patients infectés programmés pour une chirurgie de remplacement de prothèse de hanche ou de genou. |
|
|
| Ongoing | 2 | 10 | Europe | Ceftobiprole, Powder for concentrate for solution for infusion, MABELIO | Hospices Civils de Lyon, Basilea Pharmaceutica International AG | Bone or joint Infection Infection ostéo-articulaire, Bone or joint Infection Infection ostéo-articulaire, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
TANDEM, NCT04132115: Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC) |
|
|
| Recruiting | N/A | 104 | Europe | Piperacillin/tazobactam, Meropenem, Daptomycin, Ceftobiprole, Linezolid, Vancomycin, Fluconazol, Acyclovir, Gentamicins, Amikacin, Ganciclovir | Azienda Sanitaria-Universitaria Integrata di Udine | Therapeutic Drug Monitoring, Subarachnoid Hemorrhage, Intracerebral Hemorrhage | 10/21 | 10/21 | | |
PAC CEF, NCT04171674: Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation. |
|
|
| Not yet recruiting | N/A | 12 | Europe | Treatment with high-dose ceftobiprole (500mg loading dose followed by 2.5g under continuos infusion). | Centre Hospitalier Universitaire de Nīmes, Centre Hospitalier Lyon Sud, Hôpital Haut-Lévêque | Pneumonia | 12/21 | 06/22 | | |
RETRACE, NCT04170309: Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases |
|
|
| Completed | N/A | 428 | Europe | Ceftobiprole medocaril | Advanz Pharma, AMS Advanced Medical Services GmbH, APCER Life Sciences | Renal Insufficiency, Hepatic Insufficiency, Immunosuppression | 06/23 | 06/23 | | |
